Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO +1.33% Pretax Margin % is 9.66% as of Mar. 2026, which is 29% below its 10-year median of 13.65. The stock has 1 warning sign investors should review. Among 201 Medical Diagnostics & Research companies, Invitro International ranks better than 76.62% on this metric.
The historical rank and industry rank for Invitro International's Pretax Margin % or its related term are showing as below:
IVRO'
s Pretax Margin % Range Over the Past 10 Years
Min: 12.44 Med: 13.65 Max: 14.11
Current: 12.44
IVRO's Pretax Margin % is ranked better than 76.62% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.57
vs IVRO: 12.44
Invitro International (OTCPK:IVRO) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Invitro International Pretax Margin % Related Terms
Invitro International Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Invitro International's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVRO vs IDTA, PRPH, NSTM: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, Invitro International's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Invitro International's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International (IVRO) has a Pretax Margin % of 9.66% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Invitro International and its competitors. This is 29% below median its historical median of 13.65. Over the past decade, Invitro International's Pretax Margin % has ranged from 12.44 to 14.11. According to the industry distribution chart, Invitro International ranks #47 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 23.4%.
Is Invitro International's Pretax Margin % too high?
Invitro International's current Pretax Margin % of 9.66% is 29% below median its 10-year median of 13.65. Over the past 10 years, this metric has ranged from a low of 12.44 to a high of 14.11. Based on the distribution chart, Invitro International ranks #47 out of 201 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Pretax Margin % compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #47 out of 201 companies for Pretax Margin %. This places Invitro International in the top 23% of its industry — outperforming the majority of peers. Historically, Invitro International's own Pretax Margin % has ranged from 12.44 to 14.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Invitro International and its competitors. Invitro International's current Pretax Margin % is 9.66%, which is 29% below median its own 10-year median of 13.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 35.8% above its estimated fair value. The current Pretax Margin % is 9.66%, which is 29% below median its 10-year median of 13.65. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Invitro International (IVRO), the current Pretax Margin % is 9.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
